{"id":176963,"date":"2022-08-16T09:18:25","date_gmt":"2022-08-16T09:18:25","guid":{"rendered":"https:\/\/www.healthbenefitstimes.com\/glossary\/?p=176963"},"modified":"2022-08-16T09:18:25","modified_gmt":"2022-08-16T09:18:25","slug":"persistent-infant-hyperinsulinemic-hypoglycemia","status":"publish","type":"post","link":"https:\/\/www.healthbenefitstimes.com\/glossary\/persistent-infant-hyperinsulinemic-hypoglycemia\/","title":{"rendered":"Persistent infant hyperinsulinemic hypoglycemia"},"content":{"rendered":"<p>The most common cause of recurring low blood glucose levels in newborns. PHHI is typically caused either by diffuse overgrowth of insulin-secreting cells (beta cells) throughout the pancreas or by a single beta cell adenoma. It is characterized by the abnormal secretion of insulin despite low blood glucose levels. Neonates affected by PHHI may suffer brain injury caused by low blood glucose levels.<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The most common cause of recurring low blood glucose levels in newborns. PHHI is typically caused either by diffuse overgrowth of insulin-secreting cells (beta cells) throughout the pancreas or by a single beta cell adenoma. It is characterized by the abnormal secretion of insulin despite low blood glucose levels. Neonates affected by PHHI may suffer [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[16],"tags":[],"class_list":["post-176963","post","type-post","status-publish","format-standard","hentry","category-p"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Persistent infant hyperinsulinemic hypoglycemia - Definition of Persistent infant hyperinsulinemic hypoglycemia<\/title>\n<meta name=\"description\" content=\"The most common cause of recurring low blood glucose levels in newborns. PHHI is typically caused either by diffuse overgrowth of insulin-secreting cells (beta cells) throughout the pancreas or by a single beta cell adenoma. It is characterized by the abnormal secretion of insulin despite low blood glucose levels. Neonates affected by PHHI may suffer brain injury caused by low blood glucose levels.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.healthbenefitstimes.com\/glossary\/persistent-infant-hyperinsulinemic-hypoglycemia\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Persistent infant hyperinsulinemic hypoglycemia - Definition of Persistent infant hyperinsulinemic hypoglycemia\" \/>\n<meta property=\"og:description\" content=\"The most common cause of recurring low blood glucose levels in newborns. PHHI is typically caused either by diffuse overgrowth of insulin-secreting cells (beta cells) throughout the pancreas or by a single beta cell adenoma. It is characterized by the abnormal secretion of insulin despite low blood glucose levels. Neonates affected by PHHI may suffer brain injury caused by low blood glucose levels.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.healthbenefitstimes.com\/glossary\/persistent-infant-hyperinsulinemic-hypoglycemia\/\" \/>\n<meta property=\"og:site_name\" content=\"Glossary\" \/>\n<meta property=\"article:published_time\" content=\"2022-08-16T09:18:25+00:00\" \/>\n<meta name=\"author\" content=\"Glossary\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Glossary\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/persistent-infant-hyperinsulinemic-hypoglycemia\/\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/persistent-infant-hyperinsulinemic-hypoglycemia\/\",\"name\":\"Persistent infant hyperinsulinemic hypoglycemia - Definition of Persistent infant hyperinsulinemic hypoglycemia\",\"isPartOf\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\"},\"datePublished\":\"2022-08-16T09:18:25+00:00\",\"dateModified\":\"2022-08-16T09:18:25+00:00\",\"author\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\"},\"description\":\"The most common cause of recurring low blood glucose levels in newborns. PHHI is typically caused either by diffuse overgrowth of insulin-secreting cells (beta cells) throughout the pancreas or by a single beta cell adenoma. It is characterized by the abnormal secretion of insulin despite low blood glucose levels. Neonates affected by PHHI may suffer brain injury caused by low blood glucose levels.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/persistent-infant-hyperinsulinemic-hypoglycemia\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.healthbenefitstimes.com\/glossary\/persistent-infant-hyperinsulinemic-hypoglycemia\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/persistent-infant-hyperinsulinemic-hypoglycemia\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Persistent infant hyperinsulinemic hypoglycemia\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\",\"name\":\"Glossary\",\"description\":\"Difinitions\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\",\"name\":\"Glossary\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Persistent infant hyperinsulinemic hypoglycemia - Definition of Persistent infant hyperinsulinemic hypoglycemia","description":"The most common cause of recurring low blood glucose levels in newborns. PHHI is typically caused either by diffuse overgrowth of insulin-secreting cells (beta cells) throughout the pancreas or by a single beta cell adenoma. It is characterized by the abnormal secretion of insulin despite low blood glucose levels. Neonates affected by PHHI may suffer brain injury caused by low blood glucose levels.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.healthbenefitstimes.com\/glossary\/persistent-infant-hyperinsulinemic-hypoglycemia\/","og_locale":"en_US","og_type":"article","og_title":"Persistent infant hyperinsulinemic hypoglycemia - Definition of Persistent infant hyperinsulinemic hypoglycemia","og_description":"The most common cause of recurring low blood glucose levels in newborns. PHHI is typically caused either by diffuse overgrowth of insulin-secreting cells (beta cells) throughout the pancreas or by a single beta cell adenoma. It is characterized by the abnormal secretion of insulin despite low blood glucose levels. Neonates affected by PHHI may suffer brain injury caused by low blood glucose levels.","og_url":"https:\/\/www.healthbenefitstimes.com\/glossary\/persistent-infant-hyperinsulinemic-hypoglycemia\/","og_site_name":"Glossary","article_published_time":"2022-08-16T09:18:25+00:00","author":"Glossary","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Glossary","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/persistent-infant-hyperinsulinemic-hypoglycemia\/","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/persistent-infant-hyperinsulinemic-hypoglycemia\/","name":"Persistent infant hyperinsulinemic hypoglycemia - Definition of Persistent infant hyperinsulinemic hypoglycemia","isPartOf":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website"},"datePublished":"2022-08-16T09:18:25+00:00","dateModified":"2022-08-16T09:18:25+00:00","author":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5"},"description":"The most common cause of recurring low blood glucose levels in newborns. PHHI is typically caused either by diffuse overgrowth of insulin-secreting cells (beta cells) throughout the pancreas or by a single beta cell adenoma. It is characterized by the abnormal secretion of insulin despite low blood glucose levels. Neonates affected by PHHI may suffer brain injury caused by low blood glucose levels.","breadcrumb":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/persistent-infant-hyperinsulinemic-hypoglycemia\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.healthbenefitstimes.com\/glossary\/persistent-infant-hyperinsulinemic-hypoglycemia\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/persistent-infant-hyperinsulinemic-hypoglycemia\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.healthbenefitstimes.com\/glossary\/"},{"@type":"ListItem","position":2,"name":"Persistent infant hyperinsulinemic hypoglycemia"}]},{"@type":"WebSite","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/","name":"Glossary","description":"Difinitions","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5","name":"Glossary","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/"}]}},"_links":{"self":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/176963","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/comments?post=176963"}],"version-history":[{"count":1,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/176963\/revisions"}],"predecessor-version":[{"id":176964,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/176963\/revisions\/176964"}],"wp:attachment":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/media?parent=176963"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/categories?post=176963"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/tags?post=176963"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}